성기웅

교수
    

  #신경모세포종#뇌종양#Wilms종양#소아암#조혈모세포이식#EBS명의

학력

2002.08 서울대학교 대학원 의학과 (박사)
1997.02 서울대학교 대학원 의학과 (석사)
1988.02 서울대학교 의과대학 졸업 (의학사)
1983.02 서울대학교 의예과 수료

경력

2017.04 ~현재 성균관의대 소아청소년과학교실 주임교수
2017.04 ~현재 삼성서울병원 소아청소년과 과장
2013.0801 ~현재 삼성서울병원 인력양성센터장
2009.03 ~현재 성균관의대 삼성서울병원 교수
2009.0901 ~ 2013.07 성균관의대 삼성서울병원 소아암센터장
2002.10 ~ 2009.02 성균관의대 삼성서울병원 부교수
2002.08 ~ 2004.03 미국 인디아나의대 암센터 연수
1999.03 ~ 2002.09 성균관의대 삼성서울병원 소아과 조교수
1998.03 ~ 1999.02 성균관의대 삼성서울병원 소아과 혈액종양 전문의
1997.03 ~ 1998.02 성균관의대 삼성서울병원 소아과 혈액종양 전임의
1996.03 ~ 1997.02 서울대학교병원 소아과 혈액종양 전임의
1996.02 소아과 전문의 자격 취득
1992.03 ~ 1996.02 서울대학교병원 소아과 레지던트과정 수료
1991.05 ~ 1992.02 서울대학교병원 인턴과정 수료

논문

J CANCER SURVIV 2019 10.1007/s11764-019-00825-2
Influenza vaccination in caregivers of childhood cancer survivors
Cho1, IY; Yoo, JE; Ko, H; Shin, DW; Lee, JW; Baek, HJ; Chung, NG; Sung, KW; Song, YM

J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e254
Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma
Seo1, E; Kim, JS; Ma, YE; Cho, HW; Ju, HY; Lee, SH; Lee, JW; Yoo, KH; Sung, KW; Koo, HH

BONE MARROW TRANSPL 2019 10.1038/s41409-019-0492-6
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD)
Yoon1, JH; Yoo, KH; Sung, KW; Jung, CW; Kim, JS; Hahn, SM; Kang, HJ; Lee, JH; Im, HJ; Ahn, JS; Kook, H; Cho, B; Lee, JW

PEDIATR TRANSPLANT 2019 10.1111/petr.13397
Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate- or high-risk cytogenetics
Park1, EG; Yi, ES; Choi, YB; Sung, KW; Koo, HH; Yoo, KH

CELL PROLIFERAT 2019 10.1111/cpr.12577
Inhibition of N-myc expression sensitizes human neuroblastoma IMR-32 cells expressing caspase-8 to TRAIL
Lee1, MW; Kim, DS; Kim, HR; Park, HJ; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

LEUKEMIA 2019 10.1038/s41375-018-0373-9
Mesenchymal stem cells in suppression or progression of hematologic malignancy: current status and challenges
Lee1, MW; Ryu, S; Kim, DS; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

J KOREAN MED SCI 2019 10.3346/jkms.2019.34.e46
Impact of Day 14 Peripheral Blood Chimerism after Allogeneic Hematopoietic Stem Cell Bone Transplantation on the Treatment Outcome of Non-Malignant Disease
Choi1, YB; Lee, JW; Sung, KW; Koo, HH; Kim, HJ; Yoo, KH

TRANSL ONCOL 2018 10.1016/j.tranon.2018.08.013
Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid Tumors
Lee1, B; Lee, JW; Shim, JH; Joung, JG; Yun, JW; Bae, JS; Shin, HT; Sung, KW; Park, WY

J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e260
Treatment Outcomes in Children and Adolescents with Relapsed or Progressed Solid Tumors: a 20-year, Single-Center Study
Cho1, HW; Lee, JW; Ma, Y; Yoo, KH; Sung, KW; Koo, HH

PEDIATR BLOOD CANCER 2018 10.1002/pbc.27257
Clinical significance of MYCN amplification in patients with high-risk neuroblastoma
Lee1, JW; Son, MH; Cho, HW; Ma, YE; Yoo, KH; Sung, KW; Koo, HH

J CLIN IMMUNOL 2018 10.1007/s10875-018-0542-7
Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center
Yi1, ES; Choi, YB; Lee, NH; Lee, JW; Sung, KW; Koo, HH; Kang, ES; Kim, YJ; Yoo, KH

CANCER RES TREAT 2018 10.4143/crt.2017.283
NUDT15 Variants Cause Hematopoietic Toxicity with Low 6-TGN Levels in Children with Acute Lymphoblastic Leukemia
Yi1, ES; Choi, YB; Choi, R; Lee, NH; Lee, JW; Yoo, KH; Sung, KW; Lee, SY; Koo, HH

STEM CELL REV 2018 10.1007/s12015-018-9806-0
Human Adipose Tissue Stem Cells Promote the Growth of Acute Lymphoblastic Leukemia Cells in NOD/SCID Mice
Lee1, MW; Park, YJ; Kim, DS; Park, HJ; Jung, HL; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

TRANSPL INFECT DIS 2018 10.1111/tid.12885
Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: A single-center study in Korea
Kang1, JM; Park, KS; Kim, JM; Huh, HJ; Ki, CS; Lee, NY; Yoo, KH; Sung, KW; Koo, HH; Kim, YJ

PEDIATR TRANSPLANT 2018 10.1111/petr.13127
Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas
Lee1, JW; Lim, DH; Sung, KW; Lee, HJ; Yi, ES; Yoo, KH; Koo, HH; Suh, YL; Shin, HJ

J KOREAN NEUROSURG SOC 2018 10.3340/jkns.2018.0039
Tandem High-dose Chemotherapy and Autologous Stem Cell Transplantation in Children with Brain Tumors : Review of Single Center Experience
Sung1, KW; Lim, DH; Shin, HJ

STEM CELL REV 2018 10.1007/s12015-017-9793-6
Involvement of TLR3-Dependent PGES Expression in Immunosuppression by Human Bone Marrow Mesenchymal Stem Cells
Kim1, DS; Lee, WH; Lee, MW; Park, HJ; Jang, IK; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

CANCER LETT 2018 10.1016/j.canlet.2018.01.020
Anti-leukemic effects of PPAR gamma ligands
Ryu1, S; Kim, DS; Lee, MW; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

EBioMedicine 2018 10.1016/j.ebiom.2018.01.002
Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Interferon-gamma
Kim1, DS; Jang, IK; Lee, MW; Ko, YJ; Lee, DH; Lee, JW; Sung, KW; Koo, HH; Yoo, KH

ONCOTARGET 2017 10.18632/oncotarget.17500
ARID1B alterations identify aggressive tumors in neuroblastoma
Lee1, SH; Kim, JS; Zheng, SY; Huse, JT; Bae, JS; Lee, JW; Yoo, KH; Koo, HH; Kyung, S; Park, WY; Sung, KW

저서

저서 내용이 없습니다.

보도자료

"약 없어서 몇달씩 기다렸는데" 소아암 치료 희소식
http://www.tjb.co.kr/sub0301/bodo/view/id/41507/version/1

[양선희의 시시각각] ‘터널’에 갇힌 희귀소아암 환자들
http://news.joins.com/article/20559925

삼성서울병원 소아암센터, 童心과 교감… 삶의 희망 심는다
http://news.kmib.co.kr/article/view.asp?arcid=0007328773

포스팅

포스팅 내용이 없습니다.

영상자료

희귀 소아암 환자 '날벼락'…치료약 생산 중단 위기
http://news.jtbc.joins.com/article/article.aspx?news_id=NB11302806&pDate=20160829

발표자료

발표자료 내용이 없습니다.